OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.62 USD
+0.01 (0.62%)
Updated Feb 6, 2025 04:00 PM ET
After-Market: $1.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for OPKO Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | |
---|---|---|---|---|---|
Sales | NA | 864 | 1,004 | 1,775 | 1,435 |
Cost Of Goods | NA | 545 | 716 | 1,193 | 894 |
Gross Profit | NA | 318 | 288 | 582 | 541 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 475 | 514 | 563 | 483 |
Income After Depreciation & Amortization | 0 | -157 | -226 | 19 | 58 |
Non-Operating Income | NA | -14 | -153 | -14 | 13 |
Interest Expense | NA | 14 | 12 | 19 | 22 |
Pretax Income | NA | -184 | -392 | -14 | 49 |
Income Taxes | NA | 4 | -64 | 15 | 18 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | -1 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -189 | -328 | -30 | 31 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -189 | -328 | -30 | 31 |
Depreciation Footnote | 12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -50 | -116 | 98 | 144 |
Depreciation & Amortization (Cash Flow) | NA | 107 | 110 | 80 | 86 |
Income After Depreciation & Amortization | 0 | -157 | -226 | 19 | 58 |
Earnings Per Share Data | 12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 751.72 | 719.06 | 648.08 | 640.66 |
Diluted EPS Before Non-Recurring Items | NA | -0.25 | -0.36 | -0.05 | 0.05 |
Diluted Net EPS (GAAP) | NA | -0.25 | -0.46 | -0.05 | 0.05 |
Fiscal Year end for OPKO Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/24 | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | |
---|---|---|---|---|---|
Sales | NA | 173.63 | 182.19 | 173.69 | 181.91 |
Cost Of Goods | NA | 133.50 | 130.53 | 131.62 | 137.20 |
Gross Profit | NA | 40.13 | 51.65 | 42.07 | 44.71 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 25.91 | 113.32 | 113.55 | 113.75 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 14.22 | -61.67 | -71.48 | -69.04 |
Non-Operating Income | NA | 51.56 | 59.27 | -4.03 | 0.00 |
Interest Expense | NA | 17.36 | 8.18 | 7.69 | 3.45 |
Pretax Income | NA | 48.42 | -10.58 | -83.18 | -72.49 |
Income Taxes | NA | 23.53 | -0.28 | -1.35 | -6.02 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | -0.01 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 24.89 | -10.31 | -81.84 | -66.48 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 24.89 | -10.31 | -81.84 | -66.48 |
Earnings Per Share Data | 12/31/24 | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 998.36 | 697.21 | 706.88 | 751.51 |
Diluted EPS Before Non-Recurring Items | NA | 0.03 | -0.01 | -0.12 | -0.09 |
Diluted Net EPS (GAAP) | NA | 0.03 | -0.01 | -0.12 | -0.09 |